novo glp 1 drugs asks FDA to prevent compounders from making GLP-1 knockoffs Novo Nordisk's oral GLP-1 drug
Description
Our findings highlight the beneficial effects of GLP-1 RAs in improving survival and reducing adverse cardiac and kidney events in individuals with type 2 diabetes and AKD
N., Egan, L., Mamotte, C., Stokes, R., Gunton, J
Arch Endocrinol Metab
It can last several months before regrowth begins
Other research found a slightly higher rate of NAION in people using semaglutide, both for type 2 diabetes and weight loss
This brings annual costs to $2,388, saving over $1,500 per year compared to brand-name cash-pay pricing
